Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis.
about
Fertility preservation in young patients with cancer'An ounce of prevention is worth a pound of cure': the case for and against GnRH-agonist for fertility preservation.Clinical guide to fertility preservation in hematopoietic cell transplant recipientsFertility preservation in reproductive age women with cancer.Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update.Gonadotropin-Releasing Hormone Analog Cotreatment for the Preservation of Ovarian Function during Gonadotoxic Chemotherapy for Breast Cancer: A Meta-Analysis.Gonadotropin-releasing hormone for preservation of ovarian function during chemotherapy in lymphoma patients of reproductive age: a summary based on 434 patientsFertility preservation in women--a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT.Multiple approaches for individualized fertility protective therapy in cancer patients.Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function.Can We Keep the 'PROMISE'? AGO Breast Commission: Commentary on Recent Evidence Regarding LHRH Analogues for the Preservation of Ovarian Function.Fertility preservation in women with malignant tumors and gonadotoxic treatments.Fertility considerations in young women with hematological malignancies.Chemotherapy-Induced Amenorrhea - An UpdateClinical correlation between premature ovarian failure and a chromosomal anomaly in a 22-year-old Caucasian woman: a case report.Granulocyte colony-stimulating factor with or without stem cell factor extends time to premature ovarian insufficiency in female mice treated with alkylating chemotherapy.Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.Sexual health in hematopoietic stem cell transplant recipients.Oncofertility in Canada: gonadal protection and fertility-sparing strategies.Fertility preservation in gynecological cancers.Utility of GnRH-agonists for Fertility Preservation in Women With Operable Breast Cancer: Is It Protective?Fertility preservation: current prospects and future challenges.Fertility preservation in women.Fertility issues in cancer survivorship.Infertility in reproductive-age female cancer survivors.Preserving fertility when choosing chemotherapy regimens - the role of gonadotropin-releasing hormone agonists.Impact of age on cytotoxic-induced ovarian failure in breast cancer treated with adjuvant chemotherapy and triptorelin.Pregnancy and Glomerular Disease: A Systematic Review of the Literature with Management Guidelines.Perspectives on the co-treatment with GnRHa in female patients undergoing hematopoietic stem cell transplantationCancer and fertility preservation: international recommendations from an expert meeting.Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis.Fertility Preservation in Female Patients with Breast Cancer - a Current Overview.Fertility preservation in post-pubescent female cancer patients: A practical guideline for clinicians.Controversies over the use of GnRH agonists for reduction of chemotherapy-induced gonadotoxicity.Premature menopause - Meeting the needs.Fertility preservation practices in pediatric and adolescent cancer patients undergoing HSCT in Europe: a population-based survey.GNRH agonists and antagonists in rescue for cyclophosphamide-induced ovarian damage: friend or foe?Preservation of gonadal function in women undergoing chemotherapy: a systematic review and meta-analysis of the potential role for gonadotropin-releasing hormone agonists.Motherhood after breast cancer: can we balance fertility preservation and cancer treatment? A narrative review of the literatureFertility Preservation: Current and Future Perspectives for Oncologic Patients at Risk for Iatrogenic Premature Ovarian Insufficiency
P2860
Q26768250-2DE3C5C5-8DF1-4AAA-9DA8-C0BDD5D810B4Q30360464-671277AC-1A0B-41A2-8FB4-49ED47CDDB9AQ33809651-27C8FBB6-8F05-42D7-BBC8-5650C5DD3CF4Q34642487-7168334A-679E-4F7D-816C-CA968068F2E1Q34743455-67E70FE0-F027-4479-A9F6-366F34D98EE9Q34785329-4F50B499-D20F-4DB5-BAAB-9C8BD6B8B6B3Q35060296-C300E7E7-0526-4B76-AA6B-5BEA792E03D1Q35097386-A1B433DD-05E1-4E35-BF9C-E41EB2779830Q35664417-CDCC5A38-82D2-40C8-9EAE-7707D6E51FB8Q35776206-3C4064E2-C47D-42C5-94EE-712886AB3FDCQ35789448-F25FF686-F494-4964-8304-B4ED560EC013Q35896408-E75013E5-582F-41F3-BD6A-827B9ADE3F46Q36016181-495A71C7-309B-4C30-983B-54EAFF51CC67Q36295133-1C43F379-8F43-4875-8357-1497AC695BCCQ36462667-6871694C-4E99-4EDA-B179-B5A9C93BE99EQ36901831-871FE060-CC5F-4F88-86DF-641963AA9D09Q37213101-6AE1765F-BE7A-41D2-B618-A133E09426D6Q37239517-50796422-B11D-447C-A693-0C15D8393FD2Q37364626-C863692A-32CA-42BD-A5EB-00E4E85694B9Q37463014-22A3807A-C871-4AFB-B489-0BF6B6C86826Q37679148-86DDC977-E871-4219-B15A-564879E6C12BQ38076735-C9A1445A-1664-4AA4-B6C9-0EC2DDFD1DB0Q38156039-88CF872C-9B7B-4CE2-856A-B950E7E9DF4DQ38194105-EFA813D6-FFD7-42EE-AB7F-22A709C40989Q38343285-F0B2762F-C851-48BA-963B-F924AF74EDAEQ38397291-24011BB6-268F-4686-B4FA-7E8FEBD4EC16Q38913042-F59B0496-2262-4CEB-95DC-8D9F19523E85Q39316691-06EA1234-EAA6-44EF-8117-8D775CCD7C1BQ42635215-C1A3480A-9BA9-494B-B608-F21AB9F92BF9Q43106184-F9AEABAC-9AD6-47B3-BEE4-1CA2D79D9475Q46144166-EEE53AD6-149B-4970-83C0-369F2E187751Q47139499-76DA8A6F-C9A1-4B38-81B0-7A89351CDBA8Q47547600-5E4B2ACD-6515-404B-9FCE-19560D1E5F1FQ47656974-FB575772-FE0A-43DB-820E-1F1A1163731BQ48601380-118CB901-597F-43FC-ABE0-71EB278AB08BQ48707906-22E87BFE-39A5-450A-A49A-9EED05FDFF89Q50604899-4F32B5A1-6E4C-4617-8D44-5ECA45503D46Q53272116-7EEDB0C6-F428-4949-A6FE-6EF743D2FE1CQ57107180-16560D7A-0EA3-48F4-AE89-842BA2E33111Q57176379-0AEC3CA5-B543-4A2B-B650-403BBFB8AB97
P2860
Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gonadotropin-releasing hormone ...... atic review and meta-analysis.
@en
Gonadotropin-releasing hormone ...... atic review and meta-analysis.
@nl
type
label
Gonadotropin-releasing hormone ...... atic review and meta-analysis.
@en
Gonadotropin-releasing hormone ...... atic review and meta-analysis.
@nl
prefLabel
Gonadotropin-releasing hormone ...... atic review and meta-analysis.
@en
Gonadotropin-releasing hormone ...... atic review and meta-analysis.
@nl
P2093
P31
P1476
Gonadotropin-releasing hormone ...... atic review and meta-analysis.
@en
P2093
Ahmed M Abou-Setta
David Starks
Hesham G Al-Inany
Mohamed A Bedaiwy
Nina Desai
Tommaso Falcone
William Hurd
P304
906-14.e1-4
P356
10.1016/J.FERTNSTERT.2010.11.017
P407
P577
2010-12-10T00:00:00Z